CTIS.eu › Cities › France › Lille Cedex
Lille Cedex
France
681 total trials
304 recruiting
2024-516257-44-00
4
Multiple myeloma
2024-516335-27-00
5
anti-MAG neuropathy
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
2024-516796-33-00
4
The medical condition studied in IMMUNO-BOS is Bronchiolitis obliteran
2024-517187-36-01
10
Dominantly Inherited Alzheimer’s Disease (DIAD)
2024-517621-54-00
5
High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
2024-517699-39-00
5
high /medium risk cardiac surgery
2024-517769-17-00
4
Poor prognosis cervico-facial lymphatic malformations (Lymphangima)
2024-518138-10-00
4
Patients with DMMR and/or MSI metastatic colorectal cancer
2024-518251-31-00
5
patients hospitalized for a septic shock with hypercontractlity
2024-518394-34-00
1
stroke
2024-518437-28-00
5
Sickle cell disease
2024-518653-41-00
5
Patients with giant cell arteritis (= Horton’s disease)
2024-519133-29-00
4
Focal epilepsy
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
2024-519402-12-00
5
uncomplicated appendicitis
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
2024-519986-23-00
5
The study will involve adult women and men from 16 French centers who
2024-519994-20-00
5
Agitation Associated with Alzheimer’s Disease
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
2025-520554-11-00
5
Cardiovascular Disease
2025-520632-42-00
5
axial or predominantly axial SpA with or without psoriasis
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
2025-521039-35-00
5
Impact on delirium of the use of DEXmedetomidine as first-line sedati
Showing 25–48 of 681 trials